ÂÜÀòÂÒÂ×

Lauren Mifflin currently serves as Chief Operating Officer at Hillstar Bio and Vice President of Company Creation at Frazier Life Sciences. Previously, Lauren co-founded Ypsilon Therapeutics, where the role of Founding Chief Business Officer was held, and served as a Venture Partner at 82VS. Experience also includes a position as Senior Scientist and ALS Biology Lead at Nido Biosciences, an Operating Associate and Fellow at 5AM Ventures, and Fellow at Entrada Therapeutics. Earlier roles encompass an Associate position at Jump Capital, Consultant with Monitor Deloitte & Monitor Group, and Analyst at Insight Strategy Advisors. Academic achievements include a PhD in Biological and Biomedical Sciences from Harvard University, a Master of Medical Sciences in Immunology from Harvard Medical School, an MBA in Entrepreneurship and Finance from The University of Chicago Booth School of Business, as well as dual undergraduate degrees in Economics from The Wharton School and Neurobiology from the University of Pennsylvania.